Qube Research & Technologies (QRT)’s Sana Biotechnology SANA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-100,082	Closed	-$288K	–	3985
2026 Q1	$288K	Buy	100,082 +73,858	+282%	+$291K	﹤0.01%	2873
2025 Q4	$107K	Buy	+26,224	New	+$117K	﹤0.01%	3178
2025 Q1	–	Sell	-238,590	Closed	-$389K	–	3822
2024 Q4	$389K	Sell	238,590 -338,768	-59%	-$1.01M	﹤0.01%	2597
2024 Q3	$2.4M	Buy	577,358 +288,806	+100%	+$1.52M	﹤0.01%	1697
2024 Q2	$1.58M	Buy	288,552 +233,137	+421%	+$1.86M	﹤0.01%	1732
2024 Q1	$554K	Buy	+55,415	New	+$415K	﹤0.01%	2485
2022 Q1	–	Sell	-21,082	Closed	-$326K	–	2936
2021 Q4	$326K	Buy	+21,082	New	+$406K	﹤0.01%	1777
2021 Q3	–	Sell	-12,023	Closed	-$236K	–	2703
2021 Q2	$236K	Buy	+12,023	New	+$272K	﹤0.01%	1714

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SANA Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Sana Biotechnology (SANA) in Q2 2026, closing a stake of 100,082 shares — an estimated $288K sold.

Qube Research & Technologies (QRT) first reported a position in SANA in Q2 2021 and held it in 8 quarters. The position peaked at $2.4M in Q3 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Qube Research & Technologies (QRT) reported no remaining Sana Biotechnology position as of Q2 2026 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 100,082 Sana Biotechnology shares in Q2 2026, an estimated $288K.
Qube Research & Technologies (QRT) first reported a position in Sana Biotechnology in Q2 2021 and held it in 8 quarters.
Qube Research & Technologies (QRT)'s Sana Biotechnology position peaked at $2.4M in Q3 2024.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.